Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

This study has been completed.
Information provided by:
University of Pittsburgh Identifier:
First received: February 16, 2007
Last updated: May 15, 2008
Last verified: May 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Estimated Primary Completion Date: No date given